---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-22-000080"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2022-11-16T23:59:59+00:00"
generated_at: "2026-06-21T17:13:12.946529+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Landec Corp renames to Lifecore Biomedical; new Nasdaq ticker LFCR effective Nov 15

## Summary
- Name change from Landec Corporation to Lifecore Biomedical filed Nov 14, 2022; effective same day.
- Common stock ticker changes to LFCR on Nasdaq from LNDC, effective Nov 15, 2022.
- Corporate headquarters relocated to Chaska, MN; no change to CUSIP number.
- CEO James G. Hall and CFO John D. Morberg remain; board realigned for life sciences focus.
- No stockholder vote required; name change aligns with strategic pivot to CDMO business.

## SEC filing metadata
- accession: 0001005286-22-000080
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2022-11-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000080/0001005286-22-000080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000080/lndc-20221114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-22-000080
- JSON: https://secwatch.observer/filing/0001005286-22-000080.json
- Plain text: https://secwatch.observer/filing/0001005286-22-000080.txt

## Key facts
- Governance Changes
  LIFECORE BIOMEDICAL, INC. DE: Amended the Amended and Restated Bylaws solely to reflect the name change to Lifecore Biomedical, Inc (effective 2022-11-14).
  - Change: bylaw amendment
  - Effective: 2022-11-14
  source text: Additionally, on November 14, 2022, the Board approved and the Company executed an amendment to the Company’s Amended and Restated Bylaws solely to reflect the Name Change (the “Bylaws Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000080/0001005286-22-000080-index.htm
- Governance Changes
  LIFECORE BIOMEDICAL, INC. DE: Changed company name from Landec Corporation to Lifecore Biomedical, Inc. by filing an amendment to the Certificate of Incorporation (effective 2022-11-14).
  - Change: charter amendment
  - Effective: 2022-11-14
  source text: On November 14, 2022, Lifecore Biomedical, Inc., a Delaware corporation (the “Company”), filed an amendment to the Company’s Certificate of Incorporation (the “Charter”) with the Secretary of State of the State of Delaware to change the Company’s name from Landec Corporation to Lifecore Biomedical, Inc. (the “Name Change”), which was approved by the board of directors (the “Board”) of the Company, and which became effective on November 14, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528622000080/0001005286-22-000080-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.